Clinical trial
A Phase 4 Randomized Trial Comparing Varithena to Endothermal Ablation for the Treatment of the Great Saphenous Vein
NCT05312970 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 4 Randomized Trial Comparing Varithena to Endothermal Ablation for the Treatment of the Great Saphenous Vein
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 10, 2023
- Completion date
- April 4, 2024
- Enrollment
- 43 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.